Cat. No. | Product name | CAS No. |
DC66007 |
CDK9-IN-15
Featured
CDK9-IN-15 (compound 50) is a potent CDK9 inhibitor. |
852678-17-2 |
DC66008 |
PARP-1-IN-2
Featured
PARP-1-IN-2 (compound 11g) is a potent and BBB-penetrated PARP1 inhibitor, with an IC50 of 149 nM. PARP1-IN-2 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549. PARP1-IN-2 can induce A549 cells apoptosis. |
684234-55-7 |
DC66009 |
M4 mAChR agonist-1
Featured
M4 mAChR agonist-1 (compound 10a) is a potent M4 mAChR agonist with an EC50 >10 μM for human M4. |
785705-53-5 |
DC66010 |
HIF1-IN-3
Featured
HIF1-IN-3 (compound F4) is a potent HIF1 inhibitor with an EC50 value of 0.9 μM. HIF1-IN-3 can be used for researching anticancer. |
333314-79-7 |
DC66011 |
PARP1-IN-8
Featured
PARP1-IN-8 (compound 11c) is a potent and BBB-penetrated PARP1 inhibitor, with an IC50 of 97 nM. PARP1-IN-8 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549. |
836640-15-4 |
DC66012 |
JAMM protein inhibitor 2
Featured
JAMM protein inhibitor 2 (compound 180) is a potent JAMM protease inhibitor with IC50s of 10 μM, 46 μM and 89 μM for thrombin, Rpn11 and MMP2, respectively. JAMM protein inhibitor 2 can be used for researching anticancer |
848249-35-4 |
DC66013 | (2-(1H-benzo[d][1,2,3]triazol-1-yl)acetyl)alanine Featured | 1807790-60-8 |
DC66014 | (2-{[2-(2-fluorophenoxy)ethyl]sulfanyl}-1H-benzimidazol-1-yl)acetic acid Featured | 303134-93-2 |
DC66015 | 3-methyl-N-(3-(thiazolo[5,4-b]pyridin-2-yl)phenyl)butanamide Featured | 863592-53-4 |
DC66016 | Benzo[d]thiazol-2-ylmethyl ((2-fluorophenyl)sulfonyl)-L-alaninate Featured | 956731-22-9 |
DC66017 | WAY324208 Featured | 387371-82-6 |
DC66018 |
Sirtuin modulator 7
Featured
Sirtuin modulator 7 is a sirtuin-modulating compound which may increase the lifespan of a cell, and may be used for research of diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and flushing which would benefit from increased mitochondrial activity. |
863589-52-0 |
DC66019 | WAY327059 Featured | 702662-64-4 |
DC66020 | 4-(((3-(4-Ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)thio)methyl)benzonitrile Featured | 571174-12-4 |
DC66021 | WAY-328122 Featured | 912784-61-3 |
DC66022 | WAY-324485 Featured | 337920-42-0 |
DC66023 | WAY-642481 Featured | 22312-45-4 |
DC66024 | 2-(4-Chlorophenyl)-N-(4-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)phenyl)acetamide Featured | 370854-75-4 |
DC66025 | WAY-324284-A Featured | 524676-05-9 |
DC66026 |
HIV-IN-6
Featured
HIV-IN-6 is a HIV-Ⅰ viral replication inhibitor by targeting Src family kinases (SFK) that interact with Nef protein of the virus, such as Hck. |
301357-74-4 |
DC66027 |
CFTR corrector 9
Featured
CFTR corrector 9 (compound 42) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator. CFTR corrector 9 can be used for researching cystic fibrosis (CF) and other CFTR associated disorders. |
909861-78-5 |
DC66028 |
WAY-313170
Featured
inhibition of hedgehog signaling and phosphodiesterase; inhibition of hedgehog signaling and phosphodiesterase. |
314041-83-3 |